Skip to Main Content
BioNano Monographs

Impedimetric Biosensors for Medical Applications: Current Progress and Challenges

Editor
J. V. Rushworth
J. V. Rushworth
Search for other works by this author on:
N. A. Hirst
N. A. Hirst
Search for other works by this author on:
J. A. Goode
J. A. Goode
Search for other works by this author on:
D. J. Pike
D. J. Pike
Search for other works by this author on:
A. Ahmed
A. Ahmed
Search for other works by this author on:
P. A. Millner
P. A. Millner
Search for other works by this author on:
ISBN:
9780791860243
No. of Pages:
78
Publisher:
ASME Press
Publication date:
2013

The demand for reliable and user-friendly medical diagnostic tools that can be used at the point-of-care is well established (Soper et al., 2006; Yager et al., 2008). Point-of-care may refer to use in a clinical environment, field use by a clinician or other operative, or self-use by a patient. Commercial point-of-care diagnostic devices are currently widely available for amperometric and potentiometric electrochemical biosensors, e.g. glucose home blood sugar monitors (amperometric, (Newman and Turner, 2005)), iStat Portable Clinical Analyser (amperometric and potentiometric, see Section 5.3.3). However, at the time of writing, no impedimetric biosensors have made the transition from successful research laboratory trials to mass produced point-of-care diagnostics. In this section, we outline the main considerations associated with the transition of an impedimetric biosensor from research laboratory to widespread use.

This content is only available via PDF.
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal